High incidence of post-lumbar puncture headaches in patients with multiple sclerosis treated with natalizumab: role of intrathecal leukocytes.
Stüve
Olaf
O
Cravens
Petra D
PD
Singh
Mahendra P
MP
Frohman
Elliot M
EM
Phillips
J Theodore
JT
Remington
Gina
G
Hu
Wei
W
Hemmer
Bernhard
B
Olek
Michael J
MJ
Monson
Nancy L
NL
Racke
Michael K
MK
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D049109:Cell Proliferation / Q000187:drug effects; D002555:Cerebrospinal Fluid / Q000166:cytology; D015170:Cerebrospinal Fluid Pressure / Q000187:drug effects / Q000502:physiology; D015331:Cohort Studies; D004388:Dura Mater / Q000293:injuries / Q000503:physiopathology; D005260:Female; D006261:Headache / Q000139:chemically induced* / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D007958:Leukocyte Count; D007962:Leukocytes / Q000276:immunology*; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D000069442:Natalizumab; D013129:Spinal Puncture / Q000009:adverse effects*; D013346:Subarachnoid Space / Q000166:cytology / Q000187:drug effects / Q000503:physiopathology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab